| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000017012 |
| Receipt No. | R000019730 |
| Scientific Title | Safety and efficacy of the single joint type of Hybrid Assistive Limb (sj-HAL), a device for any arm and knee joints and specialized in intensive training, on early recovery of knee extension after surgery in patients with osteoarthritis of the knee |
| Date of disclosure of the study information | 2015/04/01 |
| Last modified on | 2020/04/16 (Ver. 5) |
| Basic information | ||
| Public title | Safety and efficacy of the single joint type of Hybrid Assistive Limb (sj-HAL), a device for any arm and knee joints and specialized in intensive training, on early recovery of knee extension after surgery in patients with osteoarthritis of the knee | |
| Acronym | Safety and efficacy of the sj-HAL on early recovery of knee extension after surgery in patients with osteoarthritis of the knee | |
| Scientific Title | Safety and efficacy of the single joint type of Hybrid Assistive Limb (sj-HAL), a device for any arm and knee joints and specialized in intensive training, on early recovery of knee extension after surgery in patients with osteoarthritis of the knee | |
| Scientific Title:Acronym | Safety and efficacy of the sj-HAL on early recovery of knee extension after surgery in patients with osteoarthritis of the knee | |
| Region |
|
|
| Condition | ||||
| Condition | osteoarthritis of the knee | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | The evaluation for safety and efficacy of the sj-HAL, on early recovery of knee extension after surgery in patients with osteoarthritis of the knee |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Phase I |
| Assessment | |
| Primary outcomes | 1. Vital signs (blood pressure, pulse rate and oxyhemoglobin saturation measured by pulse oximetry)
2. Radiological evaluation (X-ray) 3. Satisfaction with the assistance in mobility provided by HAL 4. Amount of time needed to put on and take off the apparatus 5. Adverse events |
| Key secondary outcomes | 1. Active and passive range of motion of the knee
2. Japanese orthopaedic association score for osteoarthritic knees (JOA knee score) 3. Japanese knee osteoarthritis measure (JKOM) 4. Muscle strengh of quadriceps femoris 5. 10-m walking |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Participants will do a trial fitting of HAL before knee surgery and then conduct exercises with HAL 2 or 3 times a week for about 3 weeks after knee surgery. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects must satisfy the following conditions for inclusion:
1. Patients who can be hospitalized continuously along the test schedule. 2. Understand the explanation of the experiment and express consent or refusal. 3. Have a body shape that can be fitted into HAL. 4. Be able to undergo usual physical therapy and occupational therapy. 5. Patients whose knee is straightened worse at 5 to 7 days after surgery rather than at the completion of surgery under anesthesia. |
|||
| Key exclusion criteria | 1. It is difficult to wear HAL or train using HAL due to the severe deformation of the skeletal system.
2. Patients has a complication, which can disturb the treatment using HAL. 3. The biological electrode for HAL can not be affixed to patient's skin due to the skin disease. 4. Patients who take part in other trials within last 12 weeks. |
|||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Department of Orthopaedics Surgery, Faculty of Medicine | ||||||
| Zip code | |||||||
| Address | 1-1-1 Tennodai, Tsukuba, Ibaraki | ||||||
| TEL | 029-853-3219 | ||||||
| masashiy@md.tsukuba.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Department of Orthopaedics Surgery, Faculty of Medicine | ||||||
| Zip code | |||||||
| Address | 1-1-1 Tennodai, Tsukuba, Ibaraki | ||||||
| TEL | 029-853-3219 | ||||||
| Homepage URL | |||||||
| yoshioka@md.tsukuba.ac.jp | |||||||
| Sponsor | |
| Institute | University of Tsukuba Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Orthopaedics Surgery, Faculty of Medicine, University of Tsukuba |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019730 |